Diagnosing colorectal cancer in primary care: cohort study in Sweden of qualitative faecal immunochemical tests, haemoglobin levels, and platelet counts
Tóm tắt
Colorectal cancer (CRC) diagnostics are challenging in primary care and reliable diagnostic aids are desired. Qualitative faecal immunochemical tests (FITs) have been used for suspected CRC in Sweden since the mid-2000s, but evidence regarding their effectiveness is scarce. Anaemia and thrombocytosis are both associated with CRC.
To evaluate the usefulness of qualitative FITs requested for symptomatic patients in primary care, alone and combined with findings of anaemia and thrombocytosis, in the diagnosis of CRC.
A population-based cohort study using electronic health records and data from the Swedish Cancer Register, covering five Swedish regions.
Patients aged ≥18 years in the five regions who had provided FITs requested by primary care practitioners from 1 January 2015 to 31 December 2015 were identified. FIT and blood-count data were registered and all CRC diagnoses made within 2 years were retrieved. Diagnostic measurements were calculated.
In total, 15 789 patients provided FITs (four different brands); of these patients, 304 were later diagnosed with CRC. Haemoglobin levels were available for 13 863 patients, and platelet counts for 10 973 patients. Calculated for the different FIT brands only, the sensitivities for CRC were 81.6%–100%; specificities 65.7%–79.5%; positive predictive values 4.7%–8.1%; and negative predictive values 99.5%–100%. Calculated for the finding of either a positive FIT or anaemia, the sensitivities increased to 88.9–100%. Adding thrombocytosis did not further increase the diagnostic performance.
Qualitative FITs requested in primary care seem to be useful as rule-in tests for referral when CRC is suspected. A negative FIT and no anaemia indicate a low risk of CRC.
Từ khóa
Tài liệu tham khảo
National Institute for Health and Care Excellence (2020) Suspected cancer: recognition and referral NG12 (NICE, London) http://www.nice.org.uk/guidance/ng12 (accessed 14 Oct 2020).
Regionala Cancercentrum I Samverkan [Standardised care pathway for colorectal cancer]. [Article in Swedish]. https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardforlopp (accessed 20 Oct 2020).
Sundhetsstyrelsen (2016) [The cancer patient pathway for colorectal cancer]. [Article in Danish]. https://www.sst.dk/da/Udgivelser/2016/Pakkeforloeb-for-kraeft-i-tyk--og-endetarm (accessed 20 Oct 2020).
Helsedirektoratet (2017) [The cancer patient pathway for colorectal cancer]. [Article in Norwegian]. https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-tykk-og-endetarmskreft/seksjon?Tittel=inngang-til-pakkeforlop-for-1368#risikogrupper (accessed 20 Oct 2020).
Hoff, 2017, Patient-reported adverse events after colonoscopy in Norway, Endoscopy, 49, 745, 10.1055/s-0043-105265
National Institute for Health and Care Excellence (2017) Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care DG30 (NICE, London) https://www.nice.org.uk/guidance/dg30 (accessed 14 Oct 2020).
Högberg, 2017, Diagnosing colorectal cancer and inflammatory bowel disease in primary care: the usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study, Scand J Gastroenterol, 52, 69, 10.1080/00365521.2016.1228120
Juul, 2018, The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer, Br J Cancer, 119, 471, 10.1038/s41416-018-0178-7
McSorley, 2019, Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent, Int J Colorectal Dis, 34, 401, 10.1007/s00384-018-3211-7
Bailey SER Ukoumunne OC Shephard EA Hamilton W (2017) Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. Br J Gen Pract, DOI: https://doi.org/10.3399/bjgp17X691109.
Segnan N Patnick J von Karsa L , eds (2011) European guidelines for quality assurance in colorectal cancer screening and diagnosis (Publications Office of the European Union, Luxembourg).
Equator Network (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, http://www.equator-network.org/reporting-guidelines/stard (accessed 14 Oct 2020).
Gies, 2018, Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening, Gastroenterology, 154, 93, 10.1053/j.gastro.2017.09.018
Turvill, 2018, Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer, Scand J Gastroenterol, 53, 1526, 10.1080/00365521.2018.1539761
Chapman, 2019, Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer, BJS Open, 3, 395, 10.1002/bjs5.50131
Herrero, 2018, Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study, BMC Gastroenterol, 18, 155, 10.1186/s12876-018-0887-7
Pin Vieito, 2019, High-risk symptoms and quantitative faecal immunochemical test accuracy: systematic review and meta-analysis, World J Gastroenterol, 25, 2383, 10.3748/wjg.v25.i19.2383